Wu Wei, Zhou Zuo-Ming, Lin Min, Mao Yun-Dong, Wang Wei, Yang Xiao-Yu, Liu Jia-Yin
Department of Reproductive Medicine, The First Affiliated Hospital, Nanjing, Jiangsu 210029, China.
Zhonghua Nan Ke Xue. 2011 Sep;17(9):771-4.
To compare the outcomes of intracytoplasmic sperm injection (ICSI) for infertile males with Y-chromosome microdeletions and for those with azoospermia or severe oligospermia but without Y-chromosome microdeletions.
We retrospectively analyzed 56 cycles of ICSI for 48 infertile cases with Y microdeletions (Group A) and 94 cycles for 90 cases with azoospermia or severe oligospermia but without Y-chromosome microdeletions (Group B) during the same period. We compared the two groups in the females' age, duration of infertility, males' age, number of oocytes retrieved, number of ICSI oocytes, fertilization rate, good embryo rate, number of embryos transferred, implantation rate, clinical pregnancy rate, abortion rate, live birth rate and babies' sexes.
There were no significant differences between Groups A and B in the females' age, duration of infertility, males' age, number of oocytes retrieved, number of ICSI oocytes and number of embryos transferred (P > 0.05), nor in the rates of fertilization (69.0% vs 73.2%), good embryos (53.3% vs 48.7%), implantation (24.0% vs 30.3%), biochemical pregnancy (41.1% vs 44.7%), clinical pregnancy (37.5% vs 35.1%), early abortion (4.8% vs 6.1%) and live birth (35.7% vs 29.2%) (P > 0.05).
Y-chromosome microdeletions do not affect the outcomes of ICSI. The affected couples should be informed of the necessity of prenatal genetic diagnosis before embryo implantation and the inevitability of vertical transmission to male offspring.
比较经卵胞浆内单精子注射(ICSI)治疗的Y染色体微缺失不育男性与无精子症或严重少精子症但无Y染色体微缺失的不育男性的治疗结局。
我们回顾性分析了同期48例Y微缺失不育患者的56个ICSI周期(A组)和90例无精子症或严重少精子症但无Y染色体微缺失患者的94个ICSI周期(B组)。比较两组患者的女方年龄、不孕时间、男方年龄、取卵数、ICSI卵子数、受精率、优质胚胎率、移植胚胎数、着床率、临床妊娠率、流产率、活产率及婴儿性别。
A组和B组在女方年龄、不孕时间、男方年龄、取卵数、ICSI卵子数和移植胚胎数方面无显著差异(P>0.05),受精率(69.0%对73.2%)、优质胚胎率(53.3%对48.7%)、着床率(24.0%对30.3%)、生化妊娠率(41.1%对44.7%)、临床妊娠率(37.5%对35.1%)、早期流产率(4.8%对6.1%)和活产率(35.7%对29.2%)也无显著差异(P>0.05)。
Y染色体微缺失不影响ICSI治疗结局。应告知受影响的夫妇在胚胎植入前进行产前基因诊断的必要性以及垂直遗传给男性后代的必然性。